Latest in Studies and Trials

517 words

GLP-1 drugs linked to lower kidney failure risk in bipolar disorder

Posted by cfelixcpa | Oct 21, 2026 | SF STAT! | 0 | BY; Marla Broadfoot, Ph.D. October 19, 2026 – ROCHESTER, Minn. — Mayo Clinic researchers found that GLP-1 receptor agonists, medications widely used for diabetes and weight management, were associated with a lower risk of dialysis or kidney transplantation…

Studies and Trials

Studies and Trials in Rehab: the news, the names and what changed.

  • 13 Tracked terms
  • Last 30 days Feed window

What this topic collects on

An article joins this feed when it matches these terms. Each one is also a search of its own.